Lynda Coughlan
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 8
- Genetics top 5%
- Virus-based gene therapy research 22
- Immunology top 10%
- Immune Response and Inflammation 9
- Epidemiology top 5%
- Influenza Virus Research Studies 16
- Respiratory viral infections research 9
- Animal Science and Zoology top 5%
-
- CAR-T cell therapy research 9
-
- Viral Infectious Diseases and Gene Expression in Insects 9
- RNA Interference and Gene Delivery 9
- Co-authors
- Peter PaleseSarah C. GilbertAlan L. ParkerFlorian KrammerAndrew H. BakerAdrian V. S. HillTeresa LambeAngela C. Bradshaw
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Lynda Coughlan
44 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Infectious Diseases 726
- Genetics 694
- Immunology 395
- Epidemiology 569
- Animal Science and Zoology 154
Countries citing papers authored by Lynda Coughlan
This map shows the geographic impact of Lynda Coughlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Coughlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Coughlan more than expected).
Fields of papers citing papers by Lynda Coughlan
This network shows the impact of papers produced by Lynda Coughlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Coughlan. The network helps show where Lynda Coughlan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lynda Coughlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 18 | |
| 11 | 2021 | 49 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 105 | |
| 15 | 2020 | 72 | |
| 16 | 2020 | 94 | |
| 17 | 2015 | 25 | |
| 18 | 2014 | 10 | |
| 19 | 2013 | 153 | |
| 20 | Biodistribution and retargeting of FX-binding ablated Ad5 vectors | 2010 | 1 |
About Lynda Coughlan
Lynda Coughlan is a scholar working on Genetics, Infectious Diseases and Immunology, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (22 papers), Influenza Virus Research Studies (16 papers), Respiratory viral infections research (9 papers), CAR-T cell therapy research (9 papers), Viral Infectious Diseases and Gene Expression in Insects (9 papers), RNA Interference and Gene Delivery (9 papers), Immune Response and Inflammation (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). The work is most often cited by research in Infectious Diseases (726 citations), Genetics (694 citations) and Immunology (395 citations). Lynda Coughlan has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Peter Palese, Sarah C. Gilbert, Alan L. Parker, Florian Krammer, Andrew H. Baker, Adrian V. S. Hill, Teresa Lambe, Angela C. Bradshaw, Stuart A. Nicklin and Richard Antrobus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.